WallStSmart
IMA

ImageneBio, Inc.

NASDAQ: IMA · HEALTHCARE · BIOTECHNOLOGY

$6.02
+1.52% today

Updated 2026-04-30

Market cap
$65.21M
P/E ratio
P/S ratio
81.51x
EPS (TTM)
$-9.64
Dividend yield
52W range
$4 – $18
Volume
0.4M

ImageneBio, Inc. (IMA) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20182019202020212022202320242025
Revenue$990000.00$13.75M$9.19M$30.98M$15.62M$9.16M$3.50M$800000.00
Revenue growth (YoY)+1289.2%-33.1%+237.0%-49.6%-41.3%-61.8%-77.1%
Cost of revenue$38.99M$24.94M$44.85M$47.11M$64.32M$1.02M$490000.00$1.03M
Gross profit$-38.00M$-11.19M$-35.65M$-16.12M$-48.70M$8.14M$3.50M$-233000.00
Gross margin-3838.0%-81.3%-387.8%-52.0%-311.8%88.9%100.0%-29.1%
R&D$38.56M$24.94M$44.85M$47.11M$64.32M$59.65M$32.11M$28.52M
SG&A$2.90M$7.31M$8.87M$18.02M$22.20M$24.93M$8.39M$20.73M
Operating income$-40.89M$-18.49M$-44.52M$-34.14M$-70.90M$-75.42M$-37.00M$-48.45M
Operating margin-4130.7%-134.5%-484.2%-110.2%-454.0%-823.3%-1057.1%-6056.4%
EBITDA$-40.44M$-18.25M$-44.22M$-33.59M$-70.15M$-74.40M$-35.47M$-47.42M
EBITDA margin-4085.2%-132.7%-481.0%-108.4%-449.2%-812.2%-1013.5%-5927.3%
EBIT$-40.87M$-18.49M$-44.52M$-34.14M$-70.90M$-75.42M$-37.00M$-48.45M
Interest expense
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-40.87M$-16.82M$-44.26M$-34.12M$-68.77M$-68.17M$-36.57M$-45.35M
Net income growth (YoY)+58.8%-163.2%+22.9%-101.6%+0.9%+46.4%-24.0%
Profit margin-4127.8%-122.3%-481.4%-110.1%-440.3%-744.2%-1044.8%-5668.6%